Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Abstract
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
References and Notes
(0)eLetters
eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.
Log In to Submit a ResponseNo eLetters have been published for this article yet.
Information & Authors
Information
Published In
April 2013
Copyright
Acknowledgments
Authors
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Cite as
- Jianjiong Gao et al.
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Identification of a novel inflammatory-related gene signature to evaluate the prognosis of gastric cancer patients, World Journal of Gastrointestinal Oncology, 16, 3, (945-967), (2024).https://doi.org/10.4251/wjgo.v16.i3.945
- Phospholipase A2 enzymes PLA2G2A and PLA2G12B as potential diagnostic and prognostic biomarkers in cholangiocarcinoma, World Journal of Gastrointestinal Surgery, 16, 2, (289-306), (2024).https://doi.org/10.4240/wjgs.v16.i2.289
- Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis, Cancer Research and Treatment, 56, 2, (665-674), (2024).https://doi.org/10.4143/crt.2023.864
- Gene amplification of chromatin remodeling factor SMARCC2 and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma , Oncology Letters, 27, 5, (2024).https://doi.org/10.3892/ol.2024.14329
- GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma, Oncology Letters, 27, 2, (2024).https://doi.org/10.3892/ol.2024.14219
- Building Flexible, Scalable, and Machine Learning-Ready Multimodal Oncology Datasets, Sensors, 24, 5, (1634), (2024).https://doi.org/10.3390/s24051634
- Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors, Pharmaceuticals, 17, 2, (152), (2024).https://doi.org/10.3390/ph17020152
- Mechanistic Insights into the Inhibition of a Common CTLA-4 Gene Mutation in the Cytoplasmic Domain, Molecules, 29, 6, (1330), (2024).https://doi.org/10.3390/molecules29061330
- Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis, Medicina, 60, 1, (181), (2024).https://doi.org/10.3390/medicina60010181
- The Role of SPEN Mutations as Predictive Biomarkers for Immunotherapy Response in Colorectal Cancer: Insights from a Retrospective Cohort Analysis, Journal of Personalized Medicine, 14, 2, (131), (2024).https://doi.org/10.3390/jpm14020131
- See more
View Options
Check Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
More options
Purchase access to this article
Download and print this article within 24 hours for your personal scholarly, research, and educational use.